Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 2Phase 2 1

Status

Completed 5Unknown 1

Sponsor Class

OTHER 6

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Lymphoid 2Breast 2Thoracic 1Gastrointestinal 1

Conditions

Cardiovascular Diseases 3Breast Neoplasms 2Sarcoidosis 1Rectal Neoplasms 1Metabolic Syndrome 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Lung Diseases, Interstitial 1Hodgkin Disease 1Fatigue 1Cardiotoxicity 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Blood Pressure × Clear all
NCT04636255 2026-05-04

Physical Capacity in Hodgkin Lymphoma Survivors

University of Sao Paulo General Hospital

Phase NA Completed
40 enrolled
Lymphoid

Cardiovascular Diseases, Hodgkin Disease

NCT04568161 2025-04-03

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

University of Sao Paulo General Hospital

Phase NA Completed
15 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity

NCT05108805 2025-03-27

Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting

Vanderbilt-Ingram Cancer Center

Phase 4 Completed
25 enrolled 17 charts
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02652975 2019-10-09

ABCDE

University of Aarhus

Phase NA Completed
76 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Metabolic Syndrome

NCT02246023 2016-04-14

Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy

University of Zurich

Phase 4 Completed
78 enrolled
Thoracic

Lung Neoplasms, Sarcoidosis, Lung Diseases, Interstitial

NCT02288078 2014-11-13

Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)

Clinical Research Support Center Kyush

Phase 2 Unknown
74 enrolled
Gastrointestinal

Fatigue, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡